カテゴリ： 世界, 医療/バイオ, QYResearch

アルファL-イズロニダーゼの世界市場2023年：IDUA、EC 3.2.1.76

■ 英語タイトル：Global Alpha L-Iduronidase Market Research Report 2023

調査会社QYResearch社が発行したリサーチレポート（データ管理コード：QYR23MA8662）■ 発行会社/調査会社：QYResearch
■ 商品コード：QYR23MA8662
■ 発行日：2023年3月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：98
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥435,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥652,500見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥870,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[アルファL-イズロニダーゼの世界市場2023年：IDUA、EC 3.2.1.76]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

本調査資料はアルファL-イズロニダーゼのグローバル市場について調査・分析し、世界のアルファL-イズロニダーゼ市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（IDUA、EC 3.2.1.76）、用途別セグメント分析（腫瘍、皮膚科、免疫、筋骨格系疾患）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、ArmaGen Inc、BioStrategies LC、Denali Therapeutics Inc、EdiGene Inc、Gain Therapeutics Inc、Immusoft Corp、JCR Pharmaceuticals Co Ltd、Orchard Therapeutics Plc、Ossianix Inc、Rain Bio Inc、RegenxBio Inc、Tega Therapeutics Incなどが含まれています。アルファL-イズロニダーゼのグローバル市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。新型コロナとロシア・ウクライナ戦争の影響は、アルファL-イズロニダーゼ市場規模を算出する際に考慮しました。

・アルファL-イズロニダーゼ市場の概要
- 製品の定義
- アルファL-イズロニダーゼの種類別セグメント
- 世界のアルファL-イズロニダーゼ市場規模：タイプ別分析（IDUA、EC 3.2.1.76）
- アルファL-イズロニダーゼの用途別セグメント
- 世界のアルファL-イズロニダーゼ市場規模：用途別分析（腫瘍、皮膚科、免疫、筋骨格系疾患）
- 世界のアルファL-イズロニダーゼ市場規模予測（2018年-2029年）
- アルファL-イズロニダーゼの平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- アルファL-イズロニダーゼ市場の競争状況およびトレンド

・アルファL-イズロニダーゼの地域別市場規模
- 北米のアルファL-イズロニダーゼ市場規模（2018年-2029年）
- 米国のアルファL-イズロニダーゼ市場規模（2018年-2029年）
- ヨーロッパのアルファL-イズロニダーゼ市場規模（2018年-2029年）
- アジア太平洋のアルファL-イズロニダーゼ市場規模（2018年-2029年）
- 中国のアルファL-イズロニダーゼ市場規模（2018年-2029年）
- 日本のアルファL-イズロニダーゼ市場規模（2018年-2029年）
- 韓国のアルファL-イズロニダーゼ市場規模（2018年-2029年）
- インドのアルファL-イズロニダーゼ市場規模（2018年-2029年）
- オーストラリアのアルファL-イズロニダーゼ市場規模（2018年-2029年）
- 中南米のアルファL-イズロニダーゼ市場規模（2018年-2029年）
- 中東・アフリカのアルファL-イズロニダーゼ市場規模（2018年-2029年）

・種類別セグメント：IDUA、EC 3.2.1.76
- 世界のアルファL-イズロニダーゼのタイプ別販売量（2018年-2023年）
- 世界のアルファL-イズロニダーゼのタイプ別売上（2018年-2023年）
- 世界のアルファL-イズロニダーゼのタイプ別価格

・用途別セグメント：腫瘍、皮膚科、免疫、筋骨格系疾患
- 世界のアルファL-イズロニダーゼの用途別販売量（2018年-2023年）
- 世界のアルファL-イズロニダーゼの用途別売上（2018年-2023年）
- 世界のアルファL-イズロニダーゼの用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
ArmaGen Inc、BioStrategies LC、Denali Therapeutics Inc、EdiGene Inc、Gain Therapeutics Inc、Immusoft Corp、JCR Pharmaceuticals Co Ltd、Orchard Therapeutics Plc、Ossianix Inc、Rain Bio Inc、RegenxBio Inc、Tega Therapeutics Inc

・産業チェーンと販売チャネルの分析
- アルファL-イズロニダーゼ産業チェーン分析
- アルファL-イズロニダーゼの主要原材料
- アルファL-イズロニダーゼの販売チャネル
- アルファL-イズロニダーゼのディストリビューター
- アルファL-イズロニダーゼの主要顧客

・アルファL-イズロニダーゼ市場ダイナミクス
- アルファL-イズロニダーゼの業界動向
- アルファL-イズロニダーゼ市場の成長ドライバ、課題、阻害要因

・調査の結論

・調査手法と情報源

Alpha L-Iduronidase (IDUA or EC 3.2.1.76) – Alpha L-iduronidase is an enzyme encoded by IDUA gene. It hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). The molecules developed by companies in Phase II, Preclinical and Discovery stages are 4, 6 and 2 respectively. Similarly, the universities portfolio in Discovery stages comprises 1 molecules, respectively. Report covers products from therapy areas Genetic Disorders which include indications Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ).
Highlights
The global Alpha L-Iduronidase market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Alpha L-Iduronidase is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Alpha L-Iduronidase is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Alpha L-Iduronidase include ArmaGen Inc, BioStrategies LC, Denali Therapeutics Inc, EdiGene Inc, Gain Therapeutics Inc, Immusoft Corp, JCR Pharmaceuticals Co Ltd, Orchard Therapeutics Plc and Ossianix Inc, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Alpha L-Iduronidase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alpha L-Iduronidase.
The Alpha L-Iduronidase market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Alpha L-Iduronidase market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alpha L-Iduronidase manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
ArmaGen Inc
BioStrategies LC
Denali Therapeutics Inc
EdiGene Inc
Gain Therapeutics Inc
Immusoft Corp
JCR Pharmaceuticals Co Ltd
Orchard Therapeutics Plc
Ossianix Inc
Rain Bio Inc
RegenxBio Inc
Tega Therapeutics Inc
Segment by Type
IDUA
EC 3.2.1.76
Segment by Application
Oncology
Dermatology
Immunology
Musculoskeletal Disorders
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Alpha L-Iduronidase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Alpha L-Iduronidase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Alpha L-Iduronidase Market Overview
1.1 Product Overview and Scope of Alpha L-Iduronidase
1.2 Alpha L-Iduronidase Segment by Type
1.2.1 Global Alpha L-Iduronidase Market Value Comparison by Type (2023-2029)
1.2.2 IDUA
1.2.3 EC 3.2.1.76
1.3 Alpha L-Iduronidase Segment by Application
1.3.1 Global Alpha L-Iduronidase Market Value by Application: (2023-2029)
1.3.2 Oncology
1.3.3 Dermatology
1.3.4 Immunology
1.3.5 Musculoskeletal Disorders
1.4 Global Alpha L-Iduronidase Market Size Estimates and Forecasts
1.4.1 Global Alpha L-Iduronidase Revenue 2018-2029
1.4.2 Global Alpha L-Iduronidase Sales 2018-2029
1.4.3 Global Alpha L-Iduronidase Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Alpha L-Iduronidase Market Competition by Manufacturers
2.1 Global Alpha L-Iduronidase Sales Market Share by Manufacturers (2018-2023)
2.2 Global Alpha L-Iduronidase Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Alpha L-Iduronidase Average Price by Manufacturers (2018-2023)
2.4 Global Alpha L-Iduronidase Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Alpha L-Iduronidase, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Alpha L-Iduronidase, Product Type & Application
2.7 Alpha L-Iduronidase Market Competitive Situation and Trends
2.7.1 Alpha L-Iduronidase Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Alpha L-Iduronidase Players Market Share by Revenue
2.7.3 Global Alpha L-Iduronidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alpha L-Iduronidase Retrospective Market Scenario by Region
3.1 Global Alpha L-Iduronidase Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Alpha L-Iduronidase Global Alpha L-Iduronidase Sales by Region: 2018-2029
3.2.1 Global Alpha L-Iduronidase Sales by Region: 2018-2023
3.2.2 Global Alpha L-Iduronidase Sales by Region: 2024-2029
3.3 Global Alpha L-Iduronidase Global Alpha L-Iduronidase Revenue by Region: 2018-2029
3.3.1 Global Alpha L-Iduronidase Revenue by Region: 2018-2023
3.3.2 Global Alpha L-Iduronidase Revenue by Region: 2024-2029
3.4 North America Alpha L-Iduronidase Market Facts & Figures by Country
3.4.1 North America Alpha L-Iduronidase Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Alpha L-Iduronidase Sales by Country (2018-2029)
3.4.3 North America Alpha L-Iduronidase Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Alpha L-Iduronidase Market Facts & Figures by Country
3.5.1 Europe Alpha L-Iduronidase Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Alpha L-Iduronidase Sales by Country (2018-2029)
3.5.3 Europe Alpha L-Iduronidase Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Alpha L-Iduronidase Market Facts & Figures by Country
3.6.1 Asia Pacific Alpha L-Iduronidase Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Alpha L-Iduronidase Sales by Country (2018-2029)
3.6.3 Asia Pacific Alpha L-Iduronidase Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Alpha L-Iduronidase Market Facts & Figures by Country
3.7.1 Latin America Alpha L-Iduronidase Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Alpha L-Iduronidase Sales by Country (2018-2029)
3.7.3 Latin America Alpha L-Iduronidase Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Alpha L-Iduronidase Market Facts & Figures by Country
3.8.1 Middle East and Africa Alpha L-Iduronidase Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Alpha L-Iduronidase Sales by Country (2018-2029)
3.8.3 Middle East and Africa Alpha L-Iduronidase Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Alpha L-Iduronidase Sales by Type (2018-2029)
4.1.1 Global Alpha L-Iduronidase Sales by Type (2018-2023)
4.1.2 Global Alpha L-Iduronidase Sales by Type (2024-2029)
4.1.3 Global Alpha L-Iduronidase Sales Market Share by Type (2018-2029)
4.2 Global Alpha L-Iduronidase Revenue by Type (2018-2029)
4.2.1 Global Alpha L-Iduronidase Revenue by Type (2018-2023)
4.2.2 Global Alpha L-Iduronidase Revenue by Type (2024-2029)
4.2.3 Global Alpha L-Iduronidase Revenue Market Share by Type (2018-2029)
4.3 Global Alpha L-Iduronidase Price by Type (2018-2029)
5 Segment by Application
5.1 Global Alpha L-Iduronidase Sales by Application (2018-2029)
5.1.1 Global Alpha L-Iduronidase Sales by Application (2018-2023)
5.1.2 Global Alpha L-Iduronidase Sales by Application (2024-2029)
5.1.3 Global Alpha L-Iduronidase Sales Market Share by Application (2018-2029)
5.2 Global Alpha L-Iduronidase Revenue by Application (2018-2029)
5.2.1 Global Alpha L-Iduronidase Revenue by Application (2018-2023)
5.2.2 Global Alpha L-Iduronidase Revenue by Application (2024-2029)
5.2.3 Global Alpha L-Iduronidase Revenue Market Share by Application (2018-2029)
5.3 Global Alpha L-Iduronidase Price by Application (2018-2029)
6 Key Companies Profiled
6.1 ArmaGen Inc
6.1.1 ArmaGen Inc Corporation Information
6.1.2 ArmaGen Inc Description and Business Overview
6.1.3 ArmaGen Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.1.4 ArmaGen Inc Alpha L-Iduronidase Product Portfolio
6.1.5 ArmaGen Inc Recent Developments/Updates
6.2 BioStrategies LC
6.2.1 BioStrategies LC Corporation Information
6.2.2 BioStrategies LC Description and Business Overview
6.2.3 BioStrategies LC Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.2.4 BioStrategies LC Alpha L-Iduronidase Product Portfolio
6.2.5 BioStrategies LC Recent Developments/Updates
6.3 Denali Therapeutics Inc
6.3.1 Denali Therapeutics Inc Corporation Information
6.3.2 Denali Therapeutics Inc Description and Business Overview
6.3.3 Denali Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Denali Therapeutics Inc Alpha L-Iduronidase Product Portfolio
6.3.5 Denali Therapeutics Inc Recent Developments/Updates
6.4 EdiGene Inc
6.4.1 EdiGene Inc Corporation Information
6.4.2 EdiGene Inc Description and Business Overview
6.4.3 EdiGene Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.4.4 EdiGene Inc Alpha L-Iduronidase Product Portfolio
6.4.5 EdiGene Inc Recent Developments/Updates
6.5 Gain Therapeutics Inc
6.5.1 Gain Therapeutics Inc Corporation Information
6.5.2 Gain Therapeutics Inc Description and Business Overview
6.5.3 Gain Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Gain Therapeutics Inc Alpha L-Iduronidase Product Portfolio
6.5.5 Gain Therapeutics Inc Recent Developments/Updates
6.6 Immusoft Corp
6.6.1 Immusoft Corp Corporation Information
6.6.2 Immusoft Corp Description and Business Overview
6.6.3 Immusoft Corp Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Immusoft Corp Alpha L-Iduronidase Product Portfolio
6.6.5 Immusoft Corp Recent Developments/Updates
6.7 JCR Pharmaceuticals Co Ltd
6.6.1 JCR Pharmaceuticals Co Ltd Corporation Information
6.6.2 JCR Pharmaceuticals Co Ltd Description and Business Overview
6.6.3 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.4.4 JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product Portfolio
6.7.5 JCR Pharmaceuticals Co Ltd Recent Developments/Updates
6.8 Orchard Therapeutics Plc
6.8.1 Orchard Therapeutics Plc Corporation Information
6.8.2 Orchard Therapeutics Plc Description and Business Overview
6.8.3 Orchard Therapeutics Plc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Orchard Therapeutics Plc Alpha L-Iduronidase Product Portfolio
6.8.5 Orchard Therapeutics Plc Recent Developments/Updates
6.9 Ossianix Inc
6.9.1 Ossianix Inc Corporation Information
6.9.2 Ossianix Inc Description and Business Overview
6.9.3 Ossianix Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Ossianix Inc Alpha L-Iduronidase Product Portfolio
6.9.5 Ossianix Inc Recent Developments/Updates
6.10 Rain Bio Inc
6.10.1 Rain Bio Inc Corporation Information
6.10.2 Rain Bio Inc Description and Business Overview
6.10.3 Rain Bio Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Rain Bio Inc Alpha L-Iduronidase Product Portfolio
6.10.5 Rain Bio Inc Recent Developments/Updates
6.11 RegenxBio Inc
6.11.1 RegenxBio Inc Corporation Information
6.11.2 RegenxBio Inc Alpha L-Iduronidase Description and Business Overview
6.11.3 RegenxBio Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.11.4 RegenxBio Inc Alpha L-Iduronidase Product Portfolio
6.11.5 RegenxBio Inc Recent Developments/Updates
6.12 Tega Therapeutics Inc
6.12.1 Tega Therapeutics Inc Corporation Information
6.12.2 Tega Therapeutics Inc Alpha L-Iduronidase Description and Business Overview
6.12.3 Tega Therapeutics Inc Alpha L-Iduronidase Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Tega Therapeutics Inc Alpha L-Iduronidase Product Portfolio
6.12.5 Tega Therapeutics Inc Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Alpha L-Iduronidase Industry Chain Analysis
7.2 Alpha L-Iduronidase Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Alpha L-Iduronidase Production Mode & Process
7.4 Alpha L-Iduronidase Sales and Marketing
7.4.1 Alpha L-Iduronidase Sales Channels
7.4.2 Alpha L-Iduronidase Distributors
7.5 Alpha L-Iduronidase Customers
8 Alpha L-Iduronidase Market Dynamics
8.1 Alpha L-Iduronidase Industry Trends
8.2 Alpha L-Iduronidase Market Drivers
8.3 Alpha L-Iduronidase Market Challenges
8.4 Alpha L-Iduronidase Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Tables
Table 1. Global Alpha L-Iduronidase Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Alpha L-Iduronidase Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Alpha L-Iduronidase Market Competitive Situation by Manufacturers in 2022
Table 4. Global Alpha L-Iduronidase Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Alpha L-Iduronidase Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Alpha L-Iduronidase Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Alpha L-Iduronidase Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Alpha L-Iduronidase Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Alpha L-Iduronidase, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Alpha L-Iduronidase, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Alpha L-Iduronidase, Product Type & Application
Table 12. Global Key Manufacturers of Alpha L-Iduronidase, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Alpha L-Iduronidase by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alpha L-Iduronidase as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Alpha L-Iduronidase Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Alpha L-Iduronidase Sales by Region (2018-2023) & (K Units)
Table 18. Global Alpha L-Iduronidase Sales Market Share by Region (2018-2023)
Table 19. Global Alpha L-Iduronidase Sales by Region (2024-2029) & (K Units)
Table 20. Global Alpha L-Iduronidase Sales Market Share by Region (2024-2029)
Table 21. Global Alpha L-Iduronidase Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Alpha L-Iduronidase Revenue Market Share by Region (2018-2023)
Table 23. Global Alpha L-Iduronidase Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Alpha L-Iduronidase Revenue Market Share by Region (2024-2029)
Table 25. North America Alpha L-Iduronidase Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Alpha L-Iduronidase Sales by Country (2018-2023) & (K Units)
Table 27. North America Alpha L-Iduronidase Sales by Country (2024-2029) & (K Units)
Table 28. North America Alpha L-Iduronidase Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Alpha L-Iduronidase Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Alpha L-Iduronidase Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Alpha L-Iduronidase Sales by Country (2018-2023) & (K Units)
Table 32. Europe Alpha L-Iduronidase Sales by Country (2024-2029) & (K Units)
Table 33. Europe Alpha L-Iduronidase Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Alpha L-Iduronidase Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Alpha L-Iduronidase Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Alpha L-Iduronidase Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Alpha L-Iduronidase Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Alpha L-Iduronidase Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Alpha L-Iduronidase Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Alpha L-Iduronidase Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Alpha L-Iduronidase Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Alpha L-Iduronidase Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Alpha L-Iduronidase Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Alpha L-Iduronidase Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Alpha L-Iduronidase Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Alpha L-Iduronidase Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Alpha L-Iduronidase Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Alpha L-Iduronidase Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Alpha L-Iduronidase Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Alpha L-Iduronidase Sales (K Units) by Type (2018-2023)
Table 51. Global Alpha L-Iduronidase Sales (K Units) by Type (2024-2029)
Table 52. Global Alpha L-Iduronidase Sales Market Share by Type (2018-2023)
Table 53. Global Alpha L-Iduronidase Sales Market Share by Type (2024-2029)
Table 54. Global Alpha L-Iduronidase Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Alpha L-Iduronidase Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Alpha L-Iduronidase Revenue Market Share by Type (2018-2023)
Table 57. Global Alpha L-Iduronidase Revenue Market Share by Type (2024-2029)
Table 58. Global Alpha L-Iduronidase Price (US$/Unit) by Type (2018-2023)
Table 59. Global Alpha L-Iduronidase Price (US$/Unit) by Type (2024-2029)
Table 60. Global Alpha L-Iduronidase Sales (K Units) by Application (2018-2023)
Table 61. Global Alpha L-Iduronidase Sales (K Units) by Application (2024-2029)
Table 62. Global Alpha L-Iduronidase Sales Market Share by Application (2018-2023)
Table 63. Global Alpha L-Iduronidase Sales Market Share by Application (2024-2029)
Table 64. Global Alpha L-Iduronidase Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Alpha L-Iduronidase Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Alpha L-Iduronidase Revenue Market Share by Application (2018-2023)
Table 67. Global Alpha L-Iduronidase Revenue Market Share by Application (2024-2029)
Table 68. Global Alpha L-Iduronidase Price (US$/Unit) by Application (2018-2023)
Table 69. Global Alpha L-Iduronidase Price (US$/Unit) by Application (2024-2029)
Table 70. ArmaGen Inc Corporation Information
Table 71. ArmaGen Inc Description and Business Overview
Table 72. ArmaGen Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. ArmaGen Inc Alpha L-Iduronidase Product
Table 74. ArmaGen Inc Recent Developments/Updates
Table 75. BioStrategies LC Corporation Information
Table 76. BioStrategies LC Description and Business Overview
Table 77. BioStrategies LC Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. BioStrategies LC Alpha L-Iduronidase Product
Table 79. BioStrategies LC Recent Developments/Updates
Table 80. Denali Therapeutics Inc Corporation Information
Table 81. Denali Therapeutics Inc Description and Business Overview
Table 82. Denali Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Denali Therapeutics Inc Alpha L-Iduronidase Product
Table 84. Denali Therapeutics Inc Recent Developments/Updates
Table 85. EdiGene Inc Corporation Information
Table 86. EdiGene Inc Description and Business Overview
Table 87. EdiGene Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. EdiGene Inc Alpha L-Iduronidase Product
Table 89. EdiGene Inc Recent Developments/Updates
Table 90. Gain Therapeutics Inc Corporation Information
Table 91. Gain Therapeutics Inc Description and Business Overview
Table 92. Gain Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Gain Therapeutics Inc Alpha L-Iduronidase Product
Table 94. Gain Therapeutics Inc Recent Developments/Updates
Table 95. Immusoft Corp Corporation Information
Table 96. Immusoft Corp Description and Business Overview
Table 97. Immusoft Corp Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. Immusoft Corp Alpha L-Iduronidase Product
Table 99. Immusoft Corp Recent Developments/Updates
Table 100. JCR Pharmaceuticals Co Ltd Corporation Information
Table 101. JCR Pharmaceuticals Co Ltd Description and Business Overview
Table 102. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. JCR Pharmaceuticals Co Ltd Alpha L-Iduronidase Product
Table 104. JCR Pharmaceuticals Co Ltd Recent Developments/Updates
Table 105. Orchard Therapeutics Plc Corporation Information
Table 106. Orchard Therapeutics Plc Description and Business Overview
Table 107. Orchard Therapeutics Plc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Orchard Therapeutics Plc Alpha L-Iduronidase Product
Table 109. Orchard Therapeutics Plc Recent Developments/Updates
Table 110. Ossianix Inc Corporation Information
Table 111. Ossianix Inc Description and Business Overview
Table 112. Ossianix Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Ossianix Inc Alpha L-Iduronidase Product
Table 114. Ossianix Inc Recent Developments/Updates
Table 115. Rain Bio Inc Corporation Information
Table 116. Rain Bio Inc Description and Business Overview
Table 117. Rain Bio Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Rain Bio Inc Alpha L-Iduronidase Product
Table 119. Rain Bio Inc Recent Developments/Updates
Table 120. RegenxBio Inc Corporation Information
Table 121. RegenxBio Inc Description and Business Overview
Table 122. RegenxBio Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. RegenxBio Inc Alpha L-Iduronidase Product
Table 124. RegenxBio Inc Recent Developments/Updates
Table 125. Tega Therapeutics Inc Corporation Information
Table 126. Tega Therapeutics Inc Description and Business Overview
Table 127. Tega Therapeutics Inc Alpha L-Iduronidase Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Tega Therapeutics Inc Alpha L-Iduronidase Product
Table 129. Tega Therapeutics Inc Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Alpha L-Iduronidase Distributors List
Table 133. Alpha L-Iduronidase Customers List
Table 134. Alpha L-Iduronidase Market Trends
Table 135. Alpha L-Iduronidase Market Drivers
Table 136. Alpha L-Iduronidase Market Challenges
Table 137. Alpha L-Iduronidase Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alpha L-Iduronidase
Figure 2. Global Alpha L-Iduronidase Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Alpha L-Iduronidase Market Share by Type in 2022 & 2029
Figure 4. IDUA Product Picture
Figure 5. EC 3.2.1.76 Product Picture
Figure 6. Global Alpha L-Iduronidase Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Alpha L-Iduronidase Market Share by Application in 2022 & 2029
Figure 8. Oncology
Figure 9. Dermatology
Figure 10. Immunology
Figure 11. Musculoskeletal Disorders
Figure 12. Global Alpha L-Iduronidase Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Alpha L-Iduronidase Market Size (2018-2029) & (US$ Million)
Figure 14. Global Alpha L-Iduronidase Sales (2018-2029) & (K Units)
Figure 15. Global Alpha L-Iduronidase Average Price (US$/Unit) & (2018-2029)
Figure 16. Alpha L-Iduronidase Report Years Considered
Figure 17. Alpha L-Iduronidase Sales Share by Manufacturers in 2022
Figure 18. Global Alpha L-Iduronidase Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Alpha L-Iduronidase Players: Market Share by Revenue in 2022
Figure 20. Alpha L-Iduronidase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Alpha L-Iduronidase Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Alpha L-Iduronidase Sales Market Share by Country (2018-2029)
Figure 23. North America Alpha L-Iduronidase Revenue Market Share by Country (2018-2029)
Figure 24. United States Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Alpha L-Iduronidase Sales Market Share by Country (2018-2029)
Figure 27. Europe Alpha L-Iduronidase Revenue Market Share by Country (2018-2029)
Figure 28. Germany Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Alpha L-Iduronidase Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Alpha L-Iduronidase Revenue Market Share by Region (2018-2029)
Figure 35. China Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Alpha L-Iduronidase Sales Market Share by Country (2018-2029)
Figure 45. Latin America Alpha L-Iduronidase Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Alpha L-Iduronidase Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Alpha L-Iduronidase Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Alpha L-Iduronidase Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Alpha L-Iduronidase by Type (2018-2029)
Figure 55. Global Revenue Market Share of Alpha L-Iduronidase by Type (2018-2029)
Figure 56. Global Alpha L-Iduronidase Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Alpha L-Iduronidase by Application (2018-2029)
Figure 58. Global Revenue Market Share of Alpha L-Iduronidase by Application (2018-2029)
Figure 59. Global Alpha L-Iduronidase Price (US$/Unit) by Application (2018-2029)
Figure 60. Alpha L-Iduronidase Value Chain
Figure 61. Alpha L-Iduronidase Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • アルファフェトプロテイン（AFP）定量分析キットの世界市場2023年：化学発光法、時間分解免疫蛍光法、その他
  • 自家生物製剤の世界市場2023年：脂肪組織、血漿、その他
  • 結膜炎治療薬の世界市場2023年：抗生物質、肥満細胞安定剤、コルチコステロイド、その他
  • 細胞分裂タンパク質FtsZの世界市場2023年：Dardarin、LRRK2、EC2.7.11.1
  • サケ中毒治療薬の世界市場2023年：経口、注射
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(QYR23MA8662 )"アルファL-イズロニダーゼの世界市場2023年：IDUA、EC 3.2.1.76" (英文：Global Alpha L-Iduronidase Market Research Report 2023)はQYResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。